Selected Publications
- E7386 Enhances Lenvatinib’s Antitumor Activity in Preclinical Models and Human Hepatocellular Carcinoma. Agavni Mesropian, Albert Gris-Oliver, Ugne Balaseviciute, Alka A. Potdar, Takayuki Kimura, Jialing Shen, Martí Torres-Marcén, Jordi Abril-Fornaguera, Marta Piqué-Gili, David Camell-Raventos, Judit Peix, Elisa Fernández-Martínez, Júlia Huguet-Pradell, Ana Hernández de Sande, Ieva Keraite, Roger Esteban-Fabró, Marina Bárcena-Varela, Katherine E. Lindblad, Amaia Lujambio, Ernesto Guccione, Swan Thung, Masafumi Ikeda, Masatoshi Kudo, Daniela Sia, Roser Pinyol, Josep M. Llovet. Clinical Cancer Research
- Demonstration of SLU7 as a new cancer target. Carla Rojo, Aaron Otero, Maria Elizalde, Maria Azkona, Roberto Barbero, Maria U. Latasa, Iker Uriarte, Alvaro Gutierrez-Uzquiza, Diego Alignani, Laura Guembe, Amaia Lujambio, Fernando Pastor, Maite G. Fernández-Barrena, Matias A. Ávila, Maria Arechederra, Carmen Berasain. Biomedicine and Pharmacotherapy
- Precision targeting of β-catenin induces tumor reprogramming and immunity in hepatocellular cancers. Brandon M. Lehrich, Evan R. Delgado, Tyler M. Yasaka, Silvia Liu, Catherine Cao, Yuqing Liu, Mohammad N. Taheri, Xiangnan Guan, Hartmut Koeppen, Sucha Singh, Vik Meadows, Jia Jun Liu, Anya Singh-Varma, Yekaterina Krutsenko, Minakshi Poddar, T. Kevin Hitchens, Lesley M. Foley, Binyong Liang, Alex Rialdi, Ravi P. Rai, Panari Patel, Madeline Riley, Aaron Bell, Reben Raeman, Tulin Dadali, Jason J. Luke, Ernesto Guccione, Mo R. Ebrahimkhani, Amaia Lujambio, Xin Chen, Martin Maier, Yulei Wang, Wendy Broom, Junyan Tao, Satdarshan P. Monga. Nature Communications